Now Scaling: AI-Native Drug Discovery

Decoding biology
accelerating health.

Solenyx integrates pharmaceutical precision, nutritional science, and AI-driven automation to decode complex diseases and deliver personalized therapeutic solutions.

Division I : Pharmaceuticals

Advanced
Molecular Engineering

We specialize in high-purity synthesis and clinical-grade formulations across four core therapeutic domains.

Lab Research

Peptide Synthesis

Custom synthesis ranging from research scale to industrial bulk, specializing in complex modifications.

  • 99% Analytical Purity
  • Cyclization & Labeling

Oncology Portfolio

Novel anti-cancer formulations targeting solid tumors through enhanced delivery mechanisms.

  • Targeted Delivery
  • Phase II Pipeline

General Medicine

Foundational therapies for metabolic and cardiovascular health.

  • Enhanced Bioavailability
  • Scalable Production

Oligo Formulations

Short-chain nucleotide strings designed for gene-silencing and modulation research.

  • High Stability
  • Custom Modifications

Regulatory Notice

Selected peptide sequences are intended for laboratory research use only. Not for direct human consumption unless specified.

Division II : Nutraceuticals

Bio-Optimization
Foundations

Engineered for physiological resilience through molecular-level precision.

Clinical Archives
Archived Trial Protocol
Phase: Completed
Scope: 1,400 Nodes
Case Study .08

The Neural
Archive.

I.

Genomic Sequencing

High-resolution mapping of patient data points to identify therapeutic targets.

II.

Neoantigen ID

AI models predict optimal protein structures for individualized mRNA responses.

III.

Rapid Synthesis

Our modular mRNA platform produces personalized doses in under 14 days.

Division III : Personalized Med

N-of-1
Therapeutics

Traditional medicine treats the average; we treat the individual. Our mRNA platform allows for rapid customization of vaccines based on real-time biological data.

Division IV : AI & Automation

The Industrialization
of Discovery

Our Solenyx OS platform integrates generative AI with a fully automated wet-lab ecosystem. We don't just predict molecules; we build and test them in real-time.

1.2M

Monthly Experiments

70%

Time Reduction

Robotics
Batch 402 Live

0.02ms Latency

Automated Generation

Disciplines
Of Synthesis.

Comprehensive workflows spanning spatial modeling, peptide engineering, and structural generation.

Discipline .01

Computational Pathways

We map the molecular architecture of your genetics. Evaluating billions of interaction parameters in silico before generating a single physical compound.

Explore Computations
Discipline .02

Robotic Scale

Automated high-throughput hardware orchestration, eliminating empirical error in peptide folding and synthesis.

Discipline .03

Clinical Validation

Continuous feedback loops mapping generated compounds directly to in vivo phenotypic outcomes.

Institutional Access

Request Full Literature

Systemic Intervention

The Architecture
Of Biological
Scale.

We approach healthspan extension not through isolated compound trials, but through comprehensive systemic architecture. By mapping billions of interaction parameters in silico, we synthesize targeted molecular interventions that align identically with your unique phenotypic state.

Review Biological Whitepaper
Biological Structuring
Data Analysis
Fig. 1 — Synaptic Data
Topological Precision
The Methodology

Phases Of
Creation.

PHASE .01

The Topology

The Topology

Deep molecular analysis. We chart target architectures and structural binding requirements with full computational rigor.

PHASE .02

Synthetics

Synthetics

Automated high-throughput orchestration. Physical peptides are folded and synthesized with zero empirical error.

PHASE .03

Translation

Translation

In-vivo validation mapping. Generated compounds are systematically tracked against human phenotypical outcomes.

"

Solenyx didn't just model our trial; they architected an epoch of our generative pipeline.

Julianne & Markus
Julianne & Markus
Lead Research Division

Building the infrastructure of tomorrow's medicine.

Whether you are a researcher, clinician, or partner, let's accelerate the path to better health outcomes together.